If you have health insurance we will file the claim for your PET scan. However, some carriers, including Medicare, do not cover PET studies for all indications (a non-covered diagnosis; See also "Medicare" for complete coverage information), or the carrier may not pay 100% of the claim. We will make every effort to maximize coverage, but you are ultimately responsible for payment.
If you do not have insurance coverage, it will be necessary for you to work out payment arrangements with our office before your appointment.
Whether you have insurance or not, we will happily discuss our financial hardship assistance program with you if you feel you are unable to pay the balance on your account.
We participate in several commercial insurance networks, including Blue Cross of Louisiana, Cigna, HealthPlus of Louisiana, Vantage Health Plan, Best Care, and Coventry Healthcare of Louisiana. If we are not in the network for your insurance carrier we will work with your insurance carrier to negotiate for in-network benefits since we are the only provider of PET services within a 100 mile radius of Shreveport.
Notice of Privacy Practices
IDTF Performance Standards
We gladly accept Louisiana Medicaid patients.
| INDICATION |
COVERED |
NATIONALLY
NON-COVERED
|
COVERED IN THE DATA REGISTRY |
| BRAIN |
|
|
X |
BREAST
Diagnosis
Initial staging of axillary nodes
Staging of distant metastasis
Restaging, monitoring*
|
X
X |
X
X |
|
CERVICAL
Staging as adjunct to conventional imaging
Other staging
Diagnosis, restaging, monitoring*
|
X
|
|
X
X |
COLORECTAL
Diagnosis, staging, restaging
Monitoring *
|
X |
|
X |
ESOPHAGUS
Diagnosis, staging, restaging
Monitoring *
|
X |
|
X |
HEAD AND NECK (non-CNS/thyroid)
Diagnosis, staging, restaging
Monitoring *
|
X |
|
X |
LYMPHOMA
Diagnosis, staging, restaging
Monitoring *
|
X |
|
X |
MELANOMA
Diagnosis, staging, restaging
Monitoring *
Staging of regional lymph node
|
X |
X |
X |
NON SMALL CELL LUNG CANCER
Diagnosis, staging, restaging
Monitoring *
|
X |
|
X |
| OVARIAN |
|
|
X |
| PANCREATIC |
|
|
X |
| SMALL CELL LUNG |
|
|
X |
| SOFT TISSUE SARCOMA |
|
|
X |
SOLITARY PULMONARY NODULE
(characterization) |
X |
|
|
THYROID
Staging of follicular cell tumors
Restaging of medullary cell tumors
Diagnosis, other staging & restaging Monitoring *
|
X |
|
X
X
X |
| TESTICULAR |
|
|
|
| ALL OTHER CANCERS NOT LISTED HEREIN |
|
|
X |
1. Covered nationally based on evidence of benefit. Refer to National Coverage Determination Manual for specific coverage language and limitations for each indication.
http://www.cms.hhs.gov/transmittals/downloads/R31NCD.pdf
2. Non-covered nationally based on lack of evidence sufficient to establish either benefit or harm.
http://www.cancerpetregistry.org
3. Non-covered nationally based on lack of evidence sufficient to establish either benefit or harm or no prior decision addressing this cancer. These indications will be covered when the scan is performed as part of the National PET Data Registry.
*Monitoring = monitoring response to treatment when a change in therapy is anticipated. |
